# Anifrolumab Pregnancy Study

> **NCT07049653** · — · NOT_YET_RECRUITING · sponsor: **AstraZeneca** · enrollment: 627 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07049653
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-31
- **Primary completion:** 2030-12-10
- **Final completion:** 2030-12-10
- **Target enrollment:** 627 (ESTIMATED)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07049653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07049653, "Anifrolumab Pregnancy Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07049653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*